Atrium Therapeutics, Inc.
NASDAQ: RNA
$7.93
as on
Atrium Therapeutics, Inc. Stock Performance
as on October 8, 2026 at 2:15 pm IST
Day's Low
Day's High
$7.94$8.13
-0.13%
Downside
2.52%
Upside
52 Week's Low
52 Week's High
$7.63$73.063.78%
Downside
821.31%
Upside
Atrium Therapeutics, Inc. share price movements today
- Previous Close
- $7.99
- Open
- $7.95
- Volume
- 182.7K
- Market Cap
- $136.7M
- Day's Low - High
- $7.94 - $8.13
- 52 Week Low - High
- $7.63 - $73.06
Atrium Therapeutics, Inc. Historical Returns
- 1 Month Return
- -30.13 %
- 3 Month Return
- -40.69 %
- 1 Year Return
- -83.57 %
- 3 Year Return
- + 28.11 %
- 5 Year Return
- -65.42 %
Atrium Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Atrium Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$136.7M
EPS (TTM)
-5.12
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.08
Industry PE ratio
-3.09
PEG Ratio
0.03
EBITDA
-260.1M
Revenue (TTM)
36.0M
Profit Margin
97.90%
Return On Equity TTM
-42.90%
Atrium Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Atrium Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $136.7M | -65.42% | -2.08 | 97.90% | 0.00% | |
| Neutral | $74.8B | -35.56% | -23.49 | -12.57% | 0.00% | |
| StrongBuy | $127.3B | 182.58% | 29.00 | 86.04% | 0.00% | |
| Buy | $74.8B | 34.93% | 17.64 | 84.86% | 0.50% |
Stock Returns calculator for Atrium Therapeutics, Inc. Stock including INR - Dollar returns
The Atrium Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Atrium Therapeutics, Inc. investment value today
Current value as on today
₹17,917
Returns
Returns from Atrium Therapeutics, Inc. Stock
Dollar Impact
₹1,485 (+1.48%)
Analyst Recommendation on Atrium Therapeutics, Inc. Stock
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Atrium Therapeutics, Inc.. Average target price of $25
Atrium Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Atrium Therapeutics, Inc..
What analysts predicted
68.28%UPSIDE
Target Price
$25
Current Price
$7.93
Analyzed by
3 Analysts
High
$25
Target
$25.00
Low
$25
Atrium Therapeutics, Inc. target price $25, a slight upside of 68.28% compared to current price of $7.93. According to 3 analysts rating.
Indian Investors' Interest in Atrium Therapeutics, Inc. Stock
Search interest for Atrium Therapeutics, Inc. Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:31% versus previous 30 day period
Atrium Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Atrium Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Atrium Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Atrium Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Atrium Therapeutics, Inc. News & Key Events
Insights on Atrium Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 89.1% return, outperforming this stock by 61.0%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 687.3%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -16.63M → -20.18M (in $), with an average decrease of 21.4% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 19.63M → 3.00M (in $), with an average decrease of 84.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, RNA stock has moved down by -30.1%
About Atrium Therapeutics, Inc.
| Organisation | Atrium Therapeutics, Inc. |
| Headquarters | 10578 Science Center Drive, San Diego, CA, 92121, US |
| Industry | Biotechnology |
| CEO | Kathleen Gallagher |
Key Management of Atrium Therapeutics, Inc.
Name | Title |
|---|---|
Ms. Kathleen P. Gallagher | President, CEO & Director |
Mr. Brendan Winslow | Chief Financial Officer |
Dr. Husam Younis Ph.D., Pharm.D. | Chief Scientific Officer |
Ms. Stephanie Kenney | Chief Corporate Affairs Officer |
Dr. Steven George Hughes M.B.A., M.D. | Chief Medical Officer |
Ms. Rocio Martin Hoyos | Chief Strategy Officer |
FAQs
What is Atrium Therapeutics, Inc. share price today?
Atrium Therapeutics, Inc. share price today is $7.93 as on at the close of the market. Atrium Therapeutics, Inc. share today touched a day high of $8.13 and a low of $7.94.
What is the 52 week high and 52 week low for Atrium Therapeutics, Inc. share?
Atrium Therapeutics, Inc. share touched a 52 week high of $73.06 on and a 52 week low of $7.63 on . Atrium Therapeutics, Inc. stock price today i.e. is closed at $7.93,which is 89.15% down from its 52 week high and 3.93% up from its 52 week low.
What is Atrium Therapeutics, Inc.'s market capitalisation today?
Atrium Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Atrium Therapeutics, Inc. Stock (RNA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Atrium Therapeutics, Inc. on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Atrium Therapeutics, Inc. Stock (RNA) from India?
Indian investors can start investing in Atrium Therapeutics, Inc. (RNA) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Atrium Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atrium Therapeutics, Inc. share’s latest price of $7.93 as on October 8, 2026 at 8:45 am IST, you will get 1.2610 shares of Atrium Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Atrium Therapeutics, Inc. has given to Indian investors in the last 5 years?
Atrium Therapeutics, Inc. stock has given -65.42% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?